Works matching DE "CASTRATION-resistant prostate cancer"

Results: 2955

Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia.

Published in:

EJNMMI Research, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13550-025-01280-0

By:

Bastian, Moritz B.;
Speicher, Tilman;
Blickle, Arne;
Burgard, Caroline;
Bastian, Julius L. D.;
Bartholomä, Mark;
Schaefer-Schuler, Andrea;
Maus, Stephan;
Ezziddin, Samer;
Rosar, Florian

Publication type:

Article

A branching bivariate weibull distribution model for evaluating exosomes in androgen-deprived agency in the presence of prostate cancer.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-07434-3

By:

Shanmugavalli, M.;
Jenvi Ignatia, K. Majella;
D, Mary Jiny;
Kumar, Raman;
Bishoyi, Ashok Kumar;
Renuka Jyothi, S.;
Channi, Harpreet Kaur;
Bhowmik, Abhijit;
Lozanović, Jasmina

Publication type:

Article

Androgendeprivative Therapie des Prostatakarzinoms aus geriatrischer Sicht.

Published in:

Zeitschrift für Gerontologie und Geriatrie, 2025, v. 58, n. 4, p. 324, doi. 10.1007/s00391-025-02454-0

By:

Wiedemann, A.;
Becher, K.;
Manseck, A.;
Stein, J.;
Fröhner, M.;
Fiebig, C.;
Piotrowski, A.;
Kirschner-Hermanns, R.;
Bannowsky, A.;
Wirz, S.;
Salem, J.;
Kuru, T. H.

Publication type:

Article

An example of drug repurposing: ebastine in combination with docetaxel as a treatment for metastatic castration-resistant prostate cancer–the EXUROC prostate study, a clinical trial protocol.

Published in:

BMC Urology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12894-025-01837-0

By:

Ørum, Katrine;
Stormoen, Dag R.;
Lauritsen, Jakob;
Rohde, Mikkel;
Jäättelä, Marja;
Pappot, Helle

Publication type:

Article

Effects of Non-Coding RNAs in Prostate Cancer: Diagnosis, Prognosis, and Therapy.

Published in:

Bratislava Medical Journal / Bratislavské Lekárske Listy, 2025, v. 126, n. 7, p. 1171, doi. 10.1007/s44411-025-00219-0

By:

Novakova, Zuzana Varchulova;
Milosovicova, Lubica;
Bernatova, Sona;
Neuschlova, Lucia;
Harsanyi, Stefan

Publication type:

Article

Efficacy and safety of darolutamide versus abiraterone acetate plus prednisone in combination with ADT for mHSPC: a real-world clinical retrospective study.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1608339

By:

Hu, Ting;
Zhou, Fang;
Zheng, Yang;
Luo, Bohan;
Zhang, Yongliang;
Gu, Chengpeng;
Wang, Guopeng;
Zhang, Jinze;
Tian, Jingzhi;
Nie, Yu;
Feng, Yunlin;
Ren, Shangqing;
Di, Wenjia;
Wang, Dong

Publication type:

Article

Comparison of tumour segmentation methods for dosimetry in [177Lu]Lu-PSMA I&T treated patients with metastatic castration resistant prostate cancer.

Published in:

EJNMMI Physics, 2025, v. 12, n. 1, p. 1, doi. 10.1186/s40658-025-00772-1

By:

Staanum, Peter Frøhlich;
Iversen, Peter

Publication type:

Article

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60654-z

By:

Mizuno, Kei;
Ku, Sheng-Yu;
Venkadakrishnan, Varadha Balaji;
Bakht, Martin K.;
Sigouros, Michael;
Chan, Joanna;
Trigos, Anna;
Driskill, Jordan H.;
Manohar, Jyothi;
King, Abigail;
Presser, Adam G.;
Kim, Min Jin;
Tewari, Alok K.;
Long, Henry W.;
Quigley, David;
Choueiri, Toni K.;
Balk, Steven;
Hill, Sarah;
Mosquera, Juan Miguel;
Einstein, David

Publication type:

Article

From Androgen Deprivation to Precision Therapy: A Bibliometric Review of Global Research Trends (2008–2023).

Published in:

American Journal of Men's Health, 2025, v. 19, n. 3, p. 1, doi. 10.1177/15579883251346819

By:

Huang, Longjun;
He, Wenjuan;
Guo, Yong

Publication type:

Article

3 things you should know about advancing mCRPC care: Targeted sequencing, epigenetics, and emerging strategies.

Published in:: Urology Times, 2025, v. 53, n. 6, p. 26
Publication type:: Article

UPDATES ON DRUGS, DEVICES, AND TESTS.

Published in:

Urology Times, 2025, v. 53, n. 6, p. 12

By:

Clarke, Hannah

Publication type:

Article

Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPC.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 9, p. 3199, doi. 10.1007/s00259-025-07198-y

By:

Telli, Tugce;
Lopes, Leonor;
Karpinski, Madeleine;
Pabst, Kim M.;
Grünwald, Viktor;
Shi, Kuangyu;
Hadaschik, Boris;
Kesch, Claudia;
Umutlu, Lale;
Herrmann, Ken;
Seifert, Robert;
Fendler, Wolfgang P.

Publication type:

Article

Prenylated Chalcones as Anticancer Agents Against Castration-Resistant Prostate Cancer.

Published in:

Scientia Pharmaceutica, 2025, v. 93, n. 2, p. 25, doi. 10.3390/scipharm93020025

By:

Morales-Reyna, Marcos;
Figueroa-Angulo, Elisa Elvira;
Espinoza-Hicks, José;
Camacho-Dávila, Alejandro;
López-Camarillo, César;
Vázquez-Carrillo, Laura Isabel;
Salgado-Aguayo, Alfonso;
Carlos-Reyes, Ángeles;
Álvarez-Jiménez, Violeta Deyanira;
Puente-Rivera, Jonathan;
Alvarez-Sánchez, María Elizbeth

Publication type:

Article

Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14294-7

By:

Boegemann, Martin;
Bennamoun, Mostefa;
Dourthe, Louis Marie;
Encarnacion, Juan Antonio;
Hegele, Axel;
Hellmis, Eva;
Latorzeff, Igor;
Leicht, Wolfgang;
Oñate-Celdrán, Julián;
Rosino-Sánchez, Antonio;
Hanna, Krystelle;
Lencart, Joana;
Lukac, Martin;
Schioppa, Claudio A.;
Van Sanden, Suzy;
Kramer, Gero

Publication type:

Article

Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel.

Published in:

Medicina (1010660X), 2025, v. 61, n. 6, p. 1105, doi. 10.3390/medicina61061105

By:

Taban, Hakan;
Erman, Mustafa;
Guven, Deniz Can;
Aktas, Burak Yasin;
Yilmaz, Feride;
Yaşar, Serkan;
Yildirim, Hasan Cagri;
Aslan, Ferit;
Aksoy, Sercan

Publication type:

Article

Combined immunotherapy employing Wilms' tumor 1 peptide‐pulsed dendritic cells and hormone or chemotherapeutic agents in patients with metastatic castration resistant prostate cancer.

Published in:

Therapeutic Apheresis & Dialysis, 2025, v. 29, n. 4, p. 568, doi. 10.1111/1744-9987.70016

By:

Ogasawara, Masahiro;
Miyashita, Mamiko;
Yamagishi, Yuka;
Ota, Shuichi

Publication type:

Article

Chemical Castration as an Evolving Concept: Is It a Possible Solution for Sexual Offences?

Published in:

Journal of Forensic Psychiatry & Psychology, 2021, v. 32, n. 2, p. 326, doi. 10.1080/14789949.2020.1849359

By:

Çöpür, Mazlum;
Çöpür, Sidar

Publication type:

Article

Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.

Published in:

Journal of Neuro-Oncology, 2020, v. 148, n. 3, p. 545, doi. 10.1007/s11060-020-03547-z

By:

Velasco, R.;
Mercadal, S.;
Vidal, N.;
Alañá, M.;
Barceló, M. I.;
Ibáñez-Juliá, M. J.;
Bobillo, S.;
Caldú Agud, R.;
García Molina, E.;
Martínez, P.;
Cacabelos, P.;
Muntañola, A.;
García-Catalán, G.;
Sancho, J. M.;
Camro, I.;
Lado, T.;
Erro, M. E.;
Gómez-Vicente, L.;
Salar, A.;
Caballero, A. C.

Publication type:

Article

Radiotherapy for cranial and brain metastases from prostate cancer: a systematic review.

Published in:

Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 531, doi. 10.1007/s11060-017-2460-6

By:

Sita, Timothy;
Petras, Katarina;
Wafford, Q.;
Berendsen, Mark;
Kruser, Tim

Publication type:

Article

Letter to the editor for the article "influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancer".

Published in:

World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-025-05682-6

By:

Zhang, Yi;
Feng, Shaoping;
Shi, Yao;
Chen, Jianfeng;
Zhou, Zhigang;
Zhu, Chenghua

Publication type:

Article

From testosterone to mitochondria: unveiling the metabolic consequences of abiraterone therapy.

Published in:

World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-025-05457-z

By:

Lin, Kuo-Jen;
Shao, I-Hung;
Lin, Yu-Hsiang

Publication type:

Article

Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer.

Published in:

World Journal of Urology, 2024, v. 43, n. 1, p. 1, doi. 10.1007/s00345-024-05388-1

By:

Wenzel, Mike;
Hoeh, Benedikt;
Humke, Clara;
Cano Garcia, Cristina;
Siech, Carolin;
Steuber, Thomas;
Graefen, Markus;
Traumann, Miriam;
Kluth, Luis;
Chun, Felix K. H.;
Mandel, Philipp

Publication type:

Article

Influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancer.

Published in:

World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05341-2

By:

Wenzel, Mike;
Hoeh, Benedikt;
Humke, Clara;
Koll, Florestan;
Cano Garcia, Cristina;
Siech, Carolin;
Steuber, Thomas;
Graefen, Markus;
Traumann, Miriam;
Kluth, Luis;
Chun, Felix K. H.;
Mandel, Philipp

Publication type:

Article

Enzalutamide versus abiraterone acetate in the development of new-onset or worsening type 2 diabetes mellitus in patients with metastatic castration-resistant prostate cancer: EVADE study.

Published in:

World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05280-y

By:

Bahl, Amit;
Sodatonou, Hanna;
Snjider, Robert;
Chilelli, Andrew;
Pranzo, Alessandra;
Martins, Karla;
Merseburger, Axel;
Rozario, Nigel;
Crawley, Danielle

Publication type:

Article

Baseline PSMA PET/CT parameters predict overall survival and treatment response in metastatic castration-resistant prostate cancer patients.

Published in:

European Radiology, 2025, v. 35, n. 7, p. 4223, doi. 10.1007/s00330-025-11360-3

By:

Kleiburg, Fleur;
de Geus-Oei, Lioe-Fee;
Spijkerman, Romy;
Noortman, Wyanne A.;
van Velden, Floris H. P.;
Manohar, Srirang;
Smit, Frits;
Toonen, Frank A. J.;
Luelmo, Saskia A. C.;
van der Hulle, Tom;
Heijmen, Linda

Publication type:

Article

The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases.

Published in:

European Radiology, 2024, v. 34, n. 2, p. 1146, doi. 10.1007/s00330-023-10172-7

By:

Donners, Ricardo;
Tunariu, Nina;
Tovey, Holly;
Hall, Emma;
Chua, Sue;
Cook, Gary;
Du, Yong;
Blackledge, Matthew D.;
Parker, Christopher C.;
Koh, Dow-Mu

Publication type:

Article

The prevalence and locations of bone metastases using whole-body MRI in treatment-naïve intermediate- and high-risk prostate cancer.

Published in:

2021

By:

Ottosson, Fredrik;
Baco, Eduard;
Lauritzen, Peter M.;
Rud, Erik

Publication type:

journal article

MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance.

Published in:

European Radiology, 2021, v. 31, n. 5, p. 2696, doi. 10.1007/s00330-020-07336-0

By:

Caglic, Iztok;
Sushentsev, Nikita;
Gnanapragasam, Vincent J.;
Sala, Evis;
Shaida, Nadeem;
Koo, Brendan C.;
Kozlov, Vasily;
Warren, Anne Y.;
Kastner, Christof;
Barrett, Tristan

Publication type:

Article

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study.

Published in:

European Radiology, 2020, v. 30, n. 11, p. 6042, doi. 10.1007/s00330-020-06997-1

By:

Ullrich, T.;
Arsov, C.;
Quentin, M.;
Mones, F.;
Westphalen, A. C.;
Mally, D.;
Hiester, A.;
Albers, P.;
Antoch, G.;
Schimmöller, L.

Publication type:

Article

Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer.

Published in:

2020

By:

Lecouvet, Frédéric E.;
Pasoglou, Vassiliki;
Van Nieuwenhove, Sandy;
Van Haver, Thomas;
de Broqueville, Quentin;
Denolin, Vincent;
Triqueneaux, Perrine;
Tombal, Bertrand;
Michoux, Nicolas

Publication type:

journal article

Shear-wave elastography: role in clinically significant prostate cancer with false-negative magnetic resonance imaging.

Published in:

2019

By:

Xiang, Li-Hua;
Fang, Yan;
Wan, Jing;
Xu, Guang;
Yao, Ming-Hua;
Ding, Shi-Si;
Liu, Hui;
Wu, Rong

Publication type:

journal article

Abiraterone-Induced Endocrinopathies.

Published in:

JCEM Case Reports, 2023, v. 1, n. 2, p. 1, doi. 10.1210/jcemcr/luad039

By:

Decamps, Scarlett;
Lis, Rita;
Ekanayake, Preethika

Publication type:

Article

Serum CDC42 level change during abiraterone plus prednisone treatment and its association with prognosis in metastatic castration-resistant prostate cancer patients.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02130-0

By:

Ma, Yong;
Cao, Zhihua;
Zhang, Jiacheng;
Zhu, Xu;
Zhao, Zhonghao;
Xiong, Jinguo

Publication type:

Article

The prognostic role of systemic immune-inflammation index, SII, in Metastatic Castration-Resistant Prostate Cancer patients.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02084-3

By:

Uzun, Mehmet;
Gokcek, Savas;
Kaya, Erhan;
Semiz, Huseyin Salih

Publication type:

Article

The therapeutic use of 177 Lu-PSMA-617 radioligand therapy in prostate cancer treatment: a review of literature and ongoing trials.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01680-z

By:

Konopnicki, Alexander;
Zaliznyak, Michael;
Roy, Mathews;
Jana, Bagi

Publication type:

Article

Evolution of prostate cancer therapy. Part 1.

Published in:

Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 3, p. 177, doi. 10.5603/OCP.2021.0001

By:

Potocki, Paweł M.;
Wysocki, Piotr J.

Publication type:

Article

Added Value of Whole-Body Diffusion-Weighted Imaging in Patients Undergoing Prostate-Specific Membrane Antigen Positron Emission Tomography.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 6, p. 1833, doi. 10.3390/jcm14061833

By:

Hong, Cheng William;
Behr, Spencer C.;
Jiang, Fei;
Wang, Yingbing;
Houshmand, Sina;
Hope, Thomas A.

Publication type:

Article

Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 16, p. 4585, doi. 10.3390/jcm13164585

By:

Kınıkoğlu, Oğuzcan;
Öven, Bala Başak;
Çelik, Serkan;
Alan Selçuk, Nalan;
Beydağı, Gamze;
Akçay, Kaan;
Kabasakal, Levent

Publication type:

Article

PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 22, p. 7130, doi. 10.3390/jcm12227130

By:

Urso, Luca;
Filippi, Luca;
Castello, Angelo;
Marzola, Maria Cristina;
Bartolomei, Mirco;
Cittanti, Corrado;
Florimonte, Luigia;
Castellani, Massimo;
Zucali, Paolo;
Bruni, Alessio;
Sabbatini, Roberto;
Dominici, Massimo;
Panareo, Stefano;
Evangelista, Laura

Publication type:

Article

Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 17, p. 5604, doi. 10.3390/jcm12175604

By:

Sidhu, Amanjot;
Khan, Nabeeha;
Phillips, Cameron;
Briones, Juan;
Kapoor, Anil;
Zalewski, Pawel;
Fleshner, Neil E.;
Chow, Edward;
Emmenegger, Urban

Publication type:

Article

The Complexity of Treatments and the Multidisciplinary Team—A Rare Case of Long-Term Progression—Free Survival in Prostate Cancer until Development of Liver and Brain Metastases.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 17, p. 5579, doi. 10.3390/jcm12175579

By:

Rahnea-Nita, Roxana-Andreea;
Rebegea, Laura-Florentina;
Nechifor, Alexandru;
Mareș, Cristian;
Toma, Radu-Valeriu;
Stoian, Alexandru-Rares;
Ciuhu, Anda-Natalia;
Andronache, Liliana-Florina;
Constantin, Georgiana Bianca;
Rahnea-Nita, Gabriela

Publication type:

Article

The Prognostic Nutritional Index (PNI): A New Biomarker for Determining Prognosis in Metastatic Castration-Sensitive Prostate Carcinoma.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 17, p. 5434, doi. 10.3390/jcm12175434

By:

Ellez, Halil Ibrahim;
Keskinkilic, Merve;
Semiz, Hüseyin Salih;
Arayici, Mehmet Emin;
Kısa, Erdem;
Oztop, Ilhan

Publication type:

Article

Prognostic Significance of Chromogranin A Expression in the Initial and Second Biopsies in Metastatic Prostate Cancer.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3362, doi. 10.3390/jcm12103362

By:

Huang, Zhuo;
Tang, Ying;
Wei, Yuyan;
Qian, Jingyu;
Kang, Yifan;
Wang, Duohao;
Xu, Miao;
Nie, Ling;
Chen, Xueqin;
Chen, Ni;
Zhou, Qiao

Publication type:

Article

Special Issue "Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning".

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 22, p. 6823, doi. 10.3390/jcm11226823

By:

Tokas, Theodoros

Publication type:

Article

PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1734, doi. 10.3390/jcm11061734

By:

Teyssonneau, Diego;
Thiery-Vuillemin, Antoine;
Dariane, Charles;
Barret, Eric;
Beauval, Jean-Baptiste;
Brureau, Laurent;
Créhange, Gilles;
Fiard, Gaëlle;
Fromont, Gaëlle;
Gauthé, Mathieu;
Ruffion, Alain;
Renard-Penna, Raphaële;
Mathieu, Romain;
Sargos, Paul;
Rouprêt, Morgan;
Ploussard, Guillaume;
Roubaud, Guilhem

Publication type:

Article

Biomarkers of Castrate Resistance in Prostate Cancer: Androgen Receptor Amplification and T877A Mutation Detection by Multiplex Droplet Digital PCR.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 1, p. 257, doi. 10.3390/jcm11010257

By:

Young, Francis P.;
Becker, Therese M.;
Nimir, Mohammed;
Opperman, Thomas;
Chua, Wei;
Balakrishnar, Bavanthi;
de Souza, Paul;
Ma, Yafeng

Publication type:

Article

Overview of the Development and Use of Akt Inhibitors in Prostate Cancer.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 1, p. 160, doi. 10.3390/jcm11010160

By:

Gasmi, Anis;
Roubaud, Guilhem;
Dariane, Charles;
Barret, Eric;
Beauval, Jean-Baptiste;
Brureau, Laurent;
Créhange, Gilles;
Fiard, Gaëlle;
Fromont, Gaëlle;
Gauthé, Mathieu;
Ruffion, Alain;
Renard-Penna, Raphaële;
Sargos, Paul;
Rouprêt, Morgan;
Ploussard, Guillaume;
Mathieu, Romain

Publication type:

Article

Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 5000, doi. 10.3390/jcm10215000

By:

Zhong, Shangwei;
Huang, Changhao;
Chen, Zhikang;
Chen, Zihua;
Luo, Jun-Li

Publication type:

Article

Chronoradiation Therapy for Prostate Cancer: Morning Proton Beam Therapy Ameliorates Worsening Lower Urinary Tract Symptoms.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2263, doi. 10.3390/jcm9072263

By:

Negoro, Hiromitsu;
Iizumi, Takashi;
Mori, Yutaro;
Matsumoto, Yoshitaka;
Chihara, Ichiro;
Hoshi, Akio;
Sakurai, Hideyuki;
Nishiyama, Hiroyuki;
Ishikawa, Hitoshi

Publication type:

Article

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2066, doi. 10.3390/jcm9072066

By:

León-Mateos, Luis;
Abalo, Alicia;
Casas, Helena;
Anido, Urbano;
Rapado-González, Óscar;
Vieito, María;
Suárez-Cunqueiro, Mercedes;
Gómez-Tato, Antonio;
Abal, Miguel;
López-López, Rafael;
Muinelo-Romay, Laura

Publication type:

Article